Abstract
The utility of fractional exhaled nitric oxide (FeNO) was evaluated alongside blood eosinophils in phenotyping mild asthma. Inclusion of FeNO improved classification accuracy and calibration in an adapted ISAR-based model; however, its predictive improvement was modest and its susceptibility to transient elevations suggests limited added value for routine clinical classification. Simplified algorithms may offer more accurate phenotyping in population-based settings with real-world constraints.
| Original language | English |
|---|---|
| Article number | 47 |
| Number of pages | 5 |
| Journal | npj Primary Care Respiratory Medicine |
| Volume | 35 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 27 Oct 2025 |
Keywords
- EXHALED NITRIC-OXIDE
- EXACERBATIONS
Fingerprint
Dive into the research topics of 'Refining mild asthma phenotyping with FeNO: a population-based evaluation'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver